Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trial-Reference-Cited by-同舟云学术

Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trial

Published:2024-09 Issue: Volume: Page:
ISSN:2468-1253
Container-title:The Lancet Gastroenterology & Hepatology
language:en
Short-container-title:The Lancet Gastroenterology & Hepatology

Author:

Choy Matthew C,Li Wai Suen Christopher F D,Con Danny,Boyd Kristy,Pena Raquel,Burrell Kathryn,Rosella Ourania,Proud David,Brouwer Richard,Gorelik Alexandra,Liew Danny,Connell William R,Wright Emily K,Taylor Kirstin M,Pudipeddi Aviv,Sawers Michelle,Christensen Britt,Ng Watson,Begun Jakob,Radford-Smith Graham,Garg Mayur,Martin Neal,van Langenberg Daniel R,Ding Nik S,Beswick Lauren,Leong Rupert W,Sparrow Miles P,De Cruz Peter

Funder

Janssen Pharmaceuticals Inc

National Health and Medical Research Council

Publisher

Elsevier BV

Reference25 articles.

1. Systematic review with meta-analysis: mortality in acute severe ulcerative colitis;Dong;Aliment Pharmacol Ther,2020

2. Cortisone in ulcerative colitis; final report on a therapeutic trial;Truelove;BMJ,1955

3. The pattern and outcome of acute severe colitis;Dinesen;J Crohns Colitis,2010

4. Decreasing colectomy rates for ulcerative colitis: a population-based time trend study;Kaplan;Am J Gastroenterol,2012

5. Systematic review and meta-analysis: infliximab or cyclosporine as rescue therapy in patients with severe ulcerative colitis refractory to steroids;Narula;Am J Gastroenterol,2016

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Infliximab rescue therapy in acute severe ulcerative colitis: more does not equal better;The Lancet Gastroenterology & Hepatology;2024-09